Molecular interactions between telomerase and the tumor suppressor protein p53 in vitro

被引:71
|
作者
Li, H [1 ]
Cao, Y [1 ]
Berndt, MC [1 ]
Funder, JW [1 ]
Liu, JP [1 ]
机构
[1] Baker Med Res Inst, Mol Signalling Lab, Prahran, Vic 3181, Australia
基金
英国医学研究理事会;
关键词
telomerase reverse transcriptase (TERT); telomerase-associated protein 1 (TEP1); p53; telomerase inhibitory polypeptide 1 (TEIPP1); breast cancer cells;
D O I
10.1038/sj.onc.1203061
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The telomere DNA polymerase (telomerase) and the tumor suppressor protein p53 are frequently associated with human cancers, and activation of telomerase and inactivation of p53 involved in cancer cell immortalization. In this report, we demonstrate a direct interaction of telomerase with p53 in the nuclear lysates of human breast cancer cells, and with recombinant human p53, by affinity chromatography and immunoprecipitation. On activity criteria, the interaction is between the carboxyl-terminal region of p53 and a region close to the amino-terminus of human telomerase-associated protein 1 (hTEP1). Incubation of recombinant p53 with nuclear telomerase extracts results in inhibition of telomerase activity, with the C-terminal region of p53 being essential for inhibition. This effect is not mediated by binding to telomerase substrate DNA, but requires the region near the N-terminus of hTEP1, in that a synthetic peptide derived from this region of hTEP1 similarly inhibits telomerase activity. Together, these in vitro interactions between telomerase and p53 suggest that the activity of telomerase may be regulated by p53, downregulation of which in turn would favor up-regulation of telomerase activity in cancer cell development.
引用
收藏
页码:6785 / 6794
页数:10
相关论文
共 50 条
  • [1] Molecular interactions between telomerase and the tumor suppressor protein p53 in vitro
    He Li
    Ying Cao
    Michael C Berndt
    John W Funder
    Jun-Ping Liu
    Oncogene, 1999, 18 : 6785 - 6794
  • [2] Interactions between the tumor suppressor p53 and immune responses
    Menendez, Daniel
    Shatz, Maria
    Resnick, Michael A.
    CURRENT OPINION IN ONCOLOGY, 2013, 25 (01) : 85 - 92
  • [3] Molecular Architecture of Tumor Suppressor p53
    Viadiu, Hector
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2008, 8 (15) : 1327 - 1334
  • [4] The molecular perspective: p53 tumor suppressor
    Goodsell, DS
    STEM CELLS, 1999, 17 (03) : 189 - 190
  • [5] Structural Bioinformatics and Molecular Dynamics of p53 Tumor Suppressor Protein
    Thayer, Kelly
    Slaw, Benjamin
    Han, In
    Quinn, Taylor
    FASEB JOURNAL, 2015, 29
  • [6] Activation of the p53 tumor suppressor protein
    Vousden, KH
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2002, 1602 (01): : 47 - 59
  • [7] Regulation of the p53 tumor suppressor protein
    Oren, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (51) : 36031 - 36034
  • [8] Evaluation of the interaction between p53 tumor suppressor protein and heparin
    de Souza, Natalia Neves
    de Lemos, Gabriela Assis
    Barros, Caroline Augusto
    Ferretti, Giulia Diniz da Silva
    de Sousa, Gileno dos Santos
    da Silva, Jerson Lima
    Ramos Goncalves Vieira, Tuane Cristine
    BIOPHYSICAL REVIEWS, 2021, 13 (06) : 1361 - 1361
  • [9] Influence of anticancer drugs on interactions of tumor suppressor protein p53 with DNA
    Pivonkova, H
    Nemcova, K
    Brazdova, M
    Kasparkova, J
    Brabec, V
    Fojta, M
    FEBS JOURNAL, 2005, 272 : 562 - 562
  • [10] Bacterial cupredoxin azurin and its interactions with the tumor suppressor protein p53
    Punj, V
    Das Gupta, TK
    Chakrabarty, AM
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 312 (01) : 109 - 114